Literature DB >> 22072557

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

Luca Arcaini1, Silvia Zibellini, Emanuela Boveri, Roberta Riboni, Sara Rattotti, Marzia Varettoni, Maria Luisa Guerrera, Marco Lucioni, Annamaria Tenore, Michele Merli, Silvia Rizzi, Lucia Morello, Chiara Cavalloni, Matteo C Da Vià, Marco Paulli, Mario Cazzola.   

Abstract

The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072557     DOI: 10.1182/blood-2011-08-368209

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.

Authors:  Siyuan Xia; Ruiting Lin; Lingtao Jin; Liang Zhao; Hee-Bum Kang; Yaozhu Pan; Shuangping Liu; Guoqing Qian; Zhiyu Qian; Evmorfia Konstantakou; Baotong Zhang; Jin-Tang Dong; Young Rock Chung; Omar Abdel-Wahab; Taha Merghoub; Lu Zhou; Ragini R Kudchadkar; David H Lawson; Hanna J Khoury; Fadlo R Khuri; Lawrence H Boise; Sagar Lonial; Benjamin H Lee; Brian P Pollack; Jack L Arbiser; Jun Fan; Qun-Ying Lei; Jing Chen
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

Review 2.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

3.  A quantitative allele-specific PCR test for the BRAF V600E mutation using a single heterozygous control plasmid for quantitation: a model for qPCR testing without standard curves.

Authors:  Philippe Szankasi; N Scott Reading; Cecily P Vaughn; Josef T Prchal; David W Bahler; Todd W Kelley
Journal:  J Mol Diagn       Date:  2013-01-08       Impact factor: 5.568

4.  Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.

Authors:  Benjamin H Durham; Bartlomiej Getta; Sascha Dietrich; Justin Taylor; Helen Won; James M Bogenberger; Sasinya Scott; Eunhee Kim; Young Rock Chung; Stephen S Chung; Jennifer Hüllein; Tatjana Walther; Lu Wang; Sydney X Lu; Christopher C Oakes; Raoul Tibes; Torsten Haferlach; Barry S Taylor; Martin S Tallman; Michael F Berger; Jae H Park; Thorsten Zenz; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-08-11       Impact factor: 22.113

5.  Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.

Authors:  Xuan J Wang; Annette Kim; Shaoying Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 6.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

Review 7.  Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Authors:  Richard Rosenquist; Andreas Rosenwald; Ming-Qing Du; Gianluca Gaidano; Patricia Groenen; Andrew Wotherspoon; Paolo Ghia; Philippe Gaulard; Elias Campo; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

Review 8.  Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Authors:  Frank S Ong; Kingshuk Das; Jay Wang; Hana Vakil; Jane Z Kuo; Wendell-Lamar B Blackwell; Stephen W Lim; Mark O Goodarzi; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

Review 9.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

10.  MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32).

Authors:  Nicoletta Coccaro; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Paola Casieri; Angelo Cellamare; Crescenzio Francesco Minervini; Angela Minervini; Cosimo Cumbo; Luciana Impera; Claudia Brunetti; Paola Orsini; Elisa Parciante; Anna Mestice; Giorgina Specchia; Francesco Albano
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.